# ELEVIDYS

NDC: 60923-511
Generic name: delandistrogene moxeparvovec-rokl
Labeler / Manufacturer: Sarepta Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: INTRAVENOUS
Marketing started: 20230622

FDA application: BLA125781

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60923-511"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60923-511
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3525abcd-fbd2-46c5-9706-cffdf2e8a361